Last Price$91.71.4%
Market Cap$18.6B
LTM Market Cap
$20.9B
5Y avg
$10.1B
Medical - Instruments & Supplies industry
median
$834.6M
Stock quality & Intrinsic value
6/10
0.0% undervalued
The Cooper Companies, Inc. Market Cap
Annual
Quarterly
LTM
Crunching data... Almost there!
| Oct'05 | Oct'06 | Oct'07 | Oct'08 | Oct'09 | Oct'10 | Oct'11 | Oct'12 | Oct'13 | Oct'14 | Oct'15 | Oct'16 | Oct'17 | Oct'18 | Oct'19 | Oct'20 | Oct'21 | Oct'22 | Oct'23 | Oct'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $748.9M | $643.6M | $473.0M | $178.4M | $316.4M | $564.5M | $841.0M | $1,150.5M | $1,557.0M | $1,970.0M | $1,838.5M | $2,138.7M | $2,961.7M | $3,127.6M | $3,585.8M | $3,916.2M | $5,138.5M | $13.6B | $15.3B | $20.9B |
Overvalued or undervalued?
Check the intrinsic value for COO
and see if it's the right time to invest.
The Cooper Companies, Inc. (COO) Market Cap comparison analysis
General
LTM Market Cap
OTHER METRICS
Company name
Revenue growth
EPS growth
Net Income margin
The Cooper Companies, Inc.COO
$18.6B
8.4%
32.2%
10.1%
Median Peer Set
$17.4B
1.7%
15.9%
10.4%
Intuitive Surgical, Inc.ISRG
$207.3B
17.2%
27.7%
27.8%
Becton, Dickinson and CompanyBDX
$66.3B
4.2%
18.3%
8.4%
Alcon Inc.ALC
$46.6B
8.5%
182.9%
10.3%
ResMed Inc.RMD
$34.6B
10.9%
13.4%
21.8%
Baxter International Inc.BAX
$17.9B
(69.5%)
(100.0%)
(6.9%)
West Pharmaceutical Services, Inc.WST
$16.9B
(1.9%)
(15.5%)
17.0%
Hologic, Inc.HOLX
$14.7B
(0.0%)
81.1%
19.6%
Masimo CorporationMASI
$10.4B
0.6%
(42.5%)
4.0%
AptarGroup, Inc.ATR
$9,757.8M
2.7%
30.2%
10.5%
Repligen CorporationRGEN
$8,979.7M
(21.1%)
(80.9%)
5.6%
COO key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Oct'05 | Oct'06 | Oct'07 | Oct'08 | Oct'09 | Oct'10 | Oct'11 | Oct'12 | Oct'13 | Oct'14 | Oct'15 | Oct'16 | Oct'17 | Oct'18 | Oct'19 | Oct'20 | Oct'21 | Oct'22 | Oct'23 | Oct'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 806.6 64.6% | 859.0 6.5% | 950.6 10.7% | 1,063.2 11.8% | 1,080.4 1.6% | 1,158.5 7.2% | 1,330.8 14.9% | 1,445.1 8.6% | 1,587.7 9.9% | 1,717.8 8.2% | 1,797.1 4.6% | 1,966.8 9.4% | 2,139.0 8.8% | 2,532.8 18.4% | 2,653.4 4.8% | 2,430.9 (8.4%) | 2,922.5 20.2% | 3,308.4 13.2% | 3,593.2 8.6% | 3,895.4 8.4% |
| Cost of Goods Sold (COGS) | 309.8 | 333.0 | 431.1 | 453.1 | 483.9 | 481.8 | 526.0 | 521.1 | 560.9 | 626.2 | 726.8 | 793.7 | 773.2 | 900.5 | 896.6 | 896.1 | 966.7 | 1,168.8 | 1,235.3 | 1,299.7 |
% margin | 496.8 61.6% | 526.0 61.2% | 519.5 54.7% | 610.0 57.4% | 596.5 55.2% | 676.7 58.4% | 804.8 60.5% | 924.0 63.9% | 1,026.8 64.7% | 1,091.6 63.5% | 1,070.3 59.6% | 1,173.1 59.6% | 1,365.8 63.9% | 1,632.3 64.4% | 1,756.8 66.2% | 1,534.8 63.1% | 1,955.8 66.9% | 2,139.6 64.7% | 2,357.9 65.6% | 2,595.7 66.6% |
| Operating Expenses | 352.5 | 406.7 | 464.0 | 481.5 | 442.8 | 486.4 | 577.2 | 635.6 | 685.7 | 785.1 | 833.6 | 849.0 | 936.7 | 1,204.8 | 1,229.1 | 1,223.0 | 1,450.0 | 1,632.0 | 1,824.8 | 1,890.0 |
| Research & Development Expenses (R&D) | 42.9 | 34.5 | 39.9 | 35.5 | 33.3 | 35.3 | 43.6 | 51.7 | 58.8 | 66.3 | 69.6 | 65.4 | 69.2 | 84.8 | 86.7 | 93.3 | 92.7 | 110.3 | 137.4 | 155.1 |
| Selling, General & Administrative Expenses (SG&A) | 298.0 | 357.8 | 408.0 | 429.3 | 391.6 | 433.1 | 513.1 | 559.9 | 596.7 | 683.1 | 712.5 | 722.8 | 799.1 | 973.3 | 996.6 | 992.5 | 1,211.2 | 1,342.2 | 1,501.2 | 1,533.7 |
% margin | 135.8 16.8% | 112.9 13.1% | 45.9 4.8% | 127.0 11.9% | 149.9 13.9% | 189.9 16.4% | 227.6 17.1% | 283.4 19.6% | 305.9 19.3% | 306.5 17.8% | 236.7 13.2% | 324.1 16.5% | 429.1 20.1% | 403.1 15.9% | 546.7 20.6% | 311.8 12.8% | 505.8 17.3% | 507.6 15.3% | 533.1 14.8% | 705.7 18.1% |
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Interest Expense | 43.6 | 58.7 | 67.5 | 53.8 | 44.1 | 36.7 | 17.3 | 11.8 | 9.2 | 8.0 | 18.1 | 26.2 | 33.4 | 82.7 | 68.0 | 36.8 | 23.1 | 57.3 | 105.3 | 114.3 |
| Pre-tax Income | 108.5 | 73.3 | 0.7 | 76.2 | 114.8 | 124.4 | 192.8 | 275.5 | 312.3 | 296.5 | 215.5 | 295.6 | 394.0 | 331.9 | 477.4 | 266.5 | 491.5 | 475.3 | 412.9 | 582.3 |
% effective tax rate | 16.7 15.4% | 7.1 9.7% | 11.9 1,765.5% | 10.7 14.1% | 14.3 12.4% | 11.6 9.3% | 17.3 9.0% | 26.8 9.7% | 15.4 4.9% | 24.7 8.3% | 10.3 4.8% | 20.7 7.0% | 21.1 5.4% | 192.0 57.8% | 10.7 2.2% | 28.1 10.5% | (2,453.2) (499.1%) | 89.5 18.8% | 118.7 28.7% | 190.0 32.6% |
% margin | 91.7 11.4% | 66.2 7.7% | (11.2) (1.2%) | 65.5 6.2% | 100.5 9.3% | 112.8 9.7% | 175.4 13.2% | 248.3 17.2% | 296.2 18.7% | 269.9 15.7% | 203.5 11.3% | 273.9 13.9% | 372.9 17.4% | 139.9 5.5% | 466.7 17.6% | 238.4 9.8% | 2,944.7 100.8% | 385.8 11.7% | 294.2 8.2% | 392.3 10.1% |
| EPS | 2.06 | 1.49 | (0.25) | 1.46 | 2.23 | 2.48 | 3.74 | 5.18 | 6.09 | 5.61 | 4.20 | 5.65 | 7.63 | 2.85 | 2.36 | 1.21 | 14.96 | 1.96 | 1.49 | 1.97 |
| Diluted EPS | 2.04 | 1.44 | (0.25) | 1.43 | 2.21 | 2.43 | 3.63 | 5.05 | 5.96 | 5.51 | 4.14 | 5.59 | 7.52 | 2.81 | 2.33 | 1.20 | 14.78 | 1.94 | 1.48 | 1.96 |
% margin | 133.0 16.5% | 168.2 19.6% | 127.0 13.4% | 206.3 19.4% | 238.6 22.1% | 244.9 21.1% | 305.4 22.9% | 398.4 27.6% | 446.8 28.1% | 442.7 25.8% | 425.0 23.6% | 520.1 26.4% | 613.6 28.7% | 689.7 27.2% | 826.2 31.1% | 622.9 25.6% | 863.7 29.6% | 908.6 27.5% | 885.9 24.7% | 705.7 18.1% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is The Cooper Companies, Inc.'s Market Cap?
As of today, The Cooper Companies, Inc.'s last 12-month Market Cap is $20.9B, based on the financial report for Oct 30, 2024 (Q4’2024).
2) What is The Cooper Companies, Inc.'s Market Cap growth rate?
Over the last year, The Cooper Companies, Inc.'s Market Cap growth was 36.7%. The average annual Market Cap growth rates for The Cooper Companies, Inc. have been 61.1% over the past three years, 42.3% over the past five years.
3) Is The Cooper Companies, Inc.'s Market Cap growth rate Good?
Over the last year, The Cooper Companies, Inc.'s Market Cap growth was 36.7%, which is higher than industry growth of 0.0%. It indicates that The Cooper Companies, Inc.'s Market Cap growth is Good.